 |
News Archives
|
For the most current news, see Latest News .
2006 Press Releases
- December 11, 2006
Positive Phase 3 Results for New Fixed Oral Dose Anticoagulant Presented at 48th Annual Meeting of the American Society of Hematology
- November 10, 2006
FDA approves MIRAPEX for the treatment of moderate-to-severe primary Restless Legs Syndrome
- October 31, 2006
Boehringer Ingelheim launches PROUD study to explore possible disease-modifying effect of pramipexole
- October 12, 2006
Boehringer Ingelheim Announces Agreement to Acquire Zantac® from Johnson & Johnson
- August 24, 2006
Pramipexole safe and effective in treating restless legs syndrome, study shows
- August 23, 2006
New study of depressive symptoms in Parkinson's disease patients shows positive results for Mirapex
- June 19, 2006
New National Campaign Gives Americans “BREATHING ROOM” to Learn about COPD — Chronic Bronchitis and Emphysema — Program Designed to Increase Awareness of COPD, An Under-Recognized Disease in the United States - June 19, 2006
Multiple new studies strongly support efficacy of pramipexole in treating restless legs syndrome
- June 9, 2006
Boehringer Ingelheim Provides Update on Aptivus® (tipranavir) Clinical Trial in Treatment-Naïve HIV-Infected Patients
- May 21, 2006
Spiriva improved lung function in COPD patients of African descent
- February 23, 2006
Boehringer Ingelheim Provides Update on Study Arms of Aptivus® (tipranavir) Clinical Trial in Treatment-Naïve HIV-Infected Patients
- January 24, 2006
Ingelheim Launches Industry’s Largest Thromboembolic Disease Clinical Trial Program to Date
Full Prescribing Information